SCHEMBL9913289

SCHEMBL9913289

CCC(C)(CC)NC(C)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
PKM P14618 2/20 0.39
THRB P10828 1/20 0.38
HTT P42858 1/20 0.36
EPHX1 P07099 2/20 0.36
ACACB O00763 1/20 0.34
ALDH1A1 P00352 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CA2 P00918 1/20 0.33
PTGS1 P23219 1/20 0.33
MMP12 P39900 1/20 0.33
NFKB1 P19838 1/20 0.32
HPGD P15428 1/20 0.31
KDM4C Q9H3R0 1/20 0.31
RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25864673 0.85 ALDH1A1 (0.41) KDM4EPKMTHRBHTTEPHX1
SCHEMBL13065886 0.85 PKM (0.34) KDM4EPKMTHRBHTTEPHX1
SCHEMBL25692377 0.84 PKM (0.33) KDM4EPKMTHRBHTTEPHX1
SCHEMBL19299881 0.84 PKM (0.37) KDM4EPKMTHRBHTTEPHX1
SCHEMBL22856935 0.82 CYP1A2 (0.33) KDM4EPKMTHRBHTT
SCHEMBL21092305 0.80 NAALAD2 (0.38) KDM4EEPHX1ALDH1A1TDP1L3MBTL1
SCHEMBL13458699 0.79 ALDH1A1 (0.43) KDM4EPKMTHRBHTTEPHX1
SCHEMBL18743794 0.79 MEN1 (0.51) PKMTHRBHTTEPHX1MEN1
SCHEMBL6584558 0.78 KDM4E (0.43) KDM4EPKMTHRBHTTEPHX1
SCHEMBL6720557 0.78 HPGD (0.35) KDM4EEPHX1ALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2023-01-19 US disclosed
WO-2022270442-A1 COMPOSITION CONTAINING FLUOROPOLYETHER GROUP-CONTAINING COMPOUND ダイキン工業株式会社 2022-12-29 WO disclosed
US-11001575-B1 Benzolactam compounds as protein kinase inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2021-05-11 US disclosed
US-10457669-B2 Benzolactam compounds as protein kinase inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2019-10-29 US disclosed
US-20190047990-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2019-02-14 US disclosed
EP-3315531-A1 8-ARM POLYETHYLENE GLYCOL DERIVATIVE, MANUFACTURING METHOD AND MODIFIED BIO-RELATED SUBSTANCE THEREBY Xiamen Sinopeg Biotech Co., Ltd. (CN) 2018-05-02 EP disclosed
US-20170209359-A1 LOW VISCOSITY HAIR CARE COMPOSITION PROCTER & GAMBLE (US) 2017-07-27 US disclosed
US-20170129881-A1 TRPM8 ANTAGONISTS DOMPÉ FARMACEUTICI S.P.A. (IT) 2017-05-11 US disclosed
US-9245290-B2 Caspase inhibitors and uses thereof BUCK INSTITUTE FOR RESEARCH ON AGING (US) 2016-01-26 US disclosed
US-20140155546-A1 POLYIMIDE PRECURSOR, POLYIMIDE, AND COATING SOLUTION FOR UNDER LAYER FILM FOR IMAGE FORMATION NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-06-05 US disclosed
US-20140011847-A1 CASPASE INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-01-09 US disclosed
US-8518942-B2 Caspase inhibitors and uses thereof BUCK INSTITUTE FOR RESEARCH ON AGING (US) 2013-08-27 US disclosed
US-8198311-B2 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2012-06-12 US disclosed
US-20110269943-A1 RADIOLABELED ANNEXINS UNIVERSITY OF WASHINGTON (US) 2011-11-03 US disclosed
US-7744853-B2 Radiolabeled annexins PONIARD PHARMACEUTICALS, INC. (US) 2010-06-29 US disclosed
US-20100075961-A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075961-A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF NFRKB, NR0B1, NFKB2 KDM4E 2420/4885PKM 2512/4885THRB 195/4885
US-20170129881-A1 TRPM8 ANTAGONISTS TRPM8, TRPM7, TRPM5 KDM4E 4303/4885PKM 2478/4885THRB 1663/4885
US-20230019032-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS MAPK1, ALK, MAP3K1 KDM4E 1101/4885PKM 454/4885THRB 587/4885
US-20190047990-A1 BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS MAPK1, ALK, MAP3K1 KDM4E 1101/4885PKM 454/4885THRB 587/4885
US-20110269943-A1 RADIOLABELED ANNEXINS ANXA11, ANXA1, ANXA3 KDM4E 4743/4885PKM 4803/4885THRB 1742/4885
US-11001575-B1 Benzolactam compounds as protein kinase inhibitors MAPK1, ALK, MAP3K1 KDM4E 1086/4885PKM 471/4885THRB 611/4885
US-20170209359-A1 LOW VISCOSITY HAIR CARE COMPOSITION PSAP, POLR1C, NACA KDM4E 1690/4885PKM 3243/4885THRB 3942/4885
US-10457669-B2 Benzolactam compounds as protein kinase inhibitors MAPK1, ALK, MAP3K1 KDM4E 1101/4885PKM 454/4885THRB 587/4885
US-20140011847-A1 CASPASE INHIBITORS AND USES THEREOF CASP6, CASP3, CASP2 KDM4E 2506/4885PKM 3193/4885THRB 4644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.